MED12 and uterine corpus leiomyoma: A study of 18 uterine leiomyomas using exome sequencing identified recurrent somatic mutations in MED12 exon 2, and further investigation of 225 uterine leiomyomas revealed that, remarkably, 159 (71%) of the tumors harbored mutations 7.